Dianthus Therapeutics (DNTH) Cash from Operations (2017 - 2025)

Dianthus Therapeutics' Cash from Operations history runs 9 years deep, the most recent figure standing at 30555000.0 for Q3 2025.

• In Q3 2025, Cash from Operations fell 43.67% year-over-year to 30555000.0; the TTM figure through Sep 2025 stood at 109521000.0 (down 74.98% YoY), while the FY2024 annual figure was 78180000.0, down 112.09% from the prior year.
• Cash from Operations was 30555000.0 for Q3 2025 at Dianthus Therapeutics, down from 23892000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 16375000.0 in Q3 2022 to a low of 30555000.0 in Q3 2025.
• Historically, Cash from Operations has averaged 15037842.11 across 5 years, with a median of 14941000.0 in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash from Operations surged 216.41% in 2022, then sank 207.08% in 2024.
• A 5-year view of Cash from Operations shows it stood at 15690000.0 in 2021, then surged by 43.59% to 8851000.0 in 2022, then tumbled by 33.93% to 11854000.0 in 2023, then slumped by 131.52% to 27444000.0 in 2024, then declined by 11.34% to 30555000.0 in 2025.
• The last three Cash from Operations figures came in at 30555000.0 (Q3 2025), 23892000.0 (Q2 2025), and 27630000.0 (Q1 2025), per Business Quant data.